We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.69%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$22.4B
AUM Growth
+$745M
Cap. Flow
+$687M
Cap. Flow %
3.07%
Top 10 Hldgs %
31.51%
Holding
1,352
New
72
Increased
666
Reduced
342
Closed
71

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$191M
2
MSFT icon
Microsoft
MSFT
+$116M
3
NVDA icon
NVIDIA
NVDA
+$115M
4
AAPL icon
Apple
AAPL
+$108M
5
WY icon
Weyerhaeuser
WY
+$83.8M

Sector Composition

Rank Sector Weight
1 Real Estate 37.54%
2 Technology 23.33%
3 Communication Services 8.01%
4 Consumer Discretionary 6.37%
5 Financials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMB icon
1076
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$16K ﹤0.01%
185
+33
+22% +$3.01K
ALKS icon
1077
Alkermes
ALKS
$8.23B
$15K ﹤0.01%
534
-12,707
-96% -$365K
BTDR icon
1078
Bitdeer Technologies
BTDR
$2.26B
$15K ﹤0.01%
500
-3,000
-86% -$38.2K
KRYS icon
1079
Krystal Biotech
KRYS
$10.6B
$15K ﹤0.01%
95
-10
-10% -$1.77K
SHY icon
1080
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$15K ﹤0.01%
+179
New +$14.7K
ACLX
1081
DELISTED
Arcellx
ACLX
$14K ﹤0.01%
178
-26
-13% -$2.25K
APLS
1082
DELISTED
Apellis Pharmaceuticals
APLS
$14K ﹤0.01%
447
AXSM icon
1083
Axsome Therapeutics
AXSM
$11.8B
$14K ﹤0.01%
160
-15
-9% -$1.38K
EWW icon
1084
iShares MSCI Mexico ETF
EWW
$1.89B
$14K ﹤0.01%
300
IEI icon
1085
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
$14K ﹤0.01%
+122
New +$14.2K
OPI
1086
DELISTED
Office Properties Income Trust
OPI
$14K ﹤0.01%
14,296
ADMA icon
1087
ADMA Biologics
ADMA
$2.01B
$13K ﹤0.01%
780
-106
-12% -$1.99K
RARE icon
1088
Ultragenyx Pharmaceutical
RARE
$2.51B
$13K ﹤0.01%
305
-45
-13% -$2.23K
SRRK icon
1089
Scholar Rock
SRRK
$5.92B
$13K ﹤0.01%
309
+101
+49% +$3.29K
ALVO icon
1090
Alvotech
ALVO
$1.18B
$12K ﹤0.01%
+881
New +$10.8K
GH icon
1091
Guardant Health
GH
$18.9B
$12K ﹤0.01%
408
-60
-13% -$1.69K
IMVT icon
1092
Immunovant
IMVT
$7.9B
$12K ﹤0.01%
484
-53
-10% -$1.5K
PTCT icon
1093
PTC Therapeutics
PTCT
$6.17B
$12K ﹤0.01%
255
-34
-12% -$1.46K
CRSP icon
1094
CRISPR Therapeutics
CRSP
$4.64B
$11K ﹤0.01%
282
-45
-14% -$2.13K
MRUS
1095
DELISTED
Merus
MRUS
$11K ﹤0.01%
251
NVCR icon
1096
NovoCure
NVCR
$1.8B
$11K ﹤0.01%
357
-65
-15% -$1.38K
RYTM icon
1097
Rhythm Pharmaceuticals
RYTM
$7.34B
$11K ﹤0.01%
203
-24
-11% -$1.33K
VCYT icon
1098
Veracyte
VCYT
$4.46B
$11K ﹤0.01%
266
-5,821
-96% -$220K
VRNA
1099
DELISTED
Verona Pharma
VRNA
$11K ﹤0.01%
244
ACAD icon
1100
Acadia Pharmaceuticals
ACAD
$4.44B
$10K ﹤0.01%
549
-92
-14% -$1.49K

Similar funds

Daiwa Securities Group's Q4 2024 Portfolio in Review

As of Q4 2024, Daiwa Securities Group held 1,352 positions worth $22.4B, up 3.4% from $21.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group deployed $687M of net new capital in Q4 2024, opening 72 new positions and adding to 666 existing holdings. Its largest new stake was Curbline Properties: 2,033,334 shares worth $47.2M.

By sector, the portfolio is most concentrated in Real Estate at 38% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $118M trimmed.

  • Daiwa Securities Group's largest Q4 2024 buy was Curbline Properties: 2,033,334 shares worth $47.2M.
  • Daiwa Securities Group added most to American Tower in Q4 2024, an estimated $191M increase.
  • Daiwa Securities Group's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $118M.
  • Daiwa Securities Group fully exited State Street SPDR S&P 500 ETF Trust in Q4 2024, selling an estimated $10.3M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $22.4B portfolio in Q4 2024.
  • Daiwa Securities Group opened 72 new positions and closed 71 in Q4 2024.
  • Daiwa Securities Group's portfolio value rose 3.4% quarter-over-quarter to $22.4B.

Based on Daiwa Securities Group's 13F filing for Q4 2024, filed 7 Feb 2025.